C., C., S., T., B., C., J., E., S., S., & S., M. (2014). Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer.

C., Charoentum, Thongprasert S., Chewasakulyong B., Euathrongchit J., Sorraritchingchai S., and Munprakan S. Phase II Study of Cisplatin Combined to Irinotecan Administered Alternatingly With Docetaxel in Advanced Non-small Cell Lung Cancer. 2014.

C., Charoentum, et al. Phase II Study of Cisplatin Combined to Irinotecan Administered Alternatingly With Docetaxel in Advanced Non-small Cell Lung Cancer. 2014.